Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 12, 2023
- Accession no.
- 0001447362-23-000173
- Filed
- Dec 12, 2023
- Trade date
- Dec 8-10, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 3 derivative transactions. Open-market sales total $97.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | Common Stock | SSaleDisposed | −2,322 | $20.10F2 | −$46,672.2 | 94,895 | Direct | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −732 | $20.10F2 | −$14,713.2 | 99,482 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −732 | $20.10F2 | −$14,713.2 | 88,377 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −267 | $20.10F2 | −$5,366.7 | 14,330 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −267 | $20.10F2 | −$5,366.7 | 14,331 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −265 | $20.10F2 | −$5,326.5 | 14,332 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −267 | $20.10F2 | −$5,366.7 | 14,325 | Indirect | |
| Dec 9, 2023 | Common Stock | MOption exerciseAcquired | +33,496 | $0.00 | $0 | 128,391 | Direct | |
| Dec 9, 2023 | Common Stock | FTax withholdingDisposed | −11,481 | $20.17 | −$231,571.77 | 116,910 | Direct | |
| Dec 10, 2023 | Common Stock | MOption exerciseAcquired | +15,424 | $0.00 | $0 | 132,334 | Direct | |
| Dec 10, 2023 | Common Stock | FTax withholdingDisposed | −4,370 | $20.17 | −$88,142.9 | 127,964 | Direct | |
| Dec 10, 2023 | Common Stock | MOption exerciseAcquired | +5,363 | $0.00 | $0 | 133,327 | Direct | |
| Dec 10, 2023 | Common Stock | FTax withholdingDisposed | −2,111 | $20.17 | −$42,578.87 | 131,216 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2023 | Common Stock | MOption exerciseDisposed | −33,496 | $0.00 | $0 | 100,487 | Direct | |
| Dec 10, 2023 | Common Stock | MOption exerciseDisposed | −15,424 | $0.00 | $0 | 30,849 | Direct | |
| Dec 10, 2023 | Common Stock | MOption exerciseDisposed | −5,363 | $0.00 | $0 | 5,362 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.00 to $20.20, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.